MedTrace Logo

SBRT for Close or Positive Margins After Resection of Pancreatic Adenocarcinoma

NCT01357525 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-11-24

Study results available
· View outcomes & findings →

Summary

The current study seeks to further investigate the impact of Stereotactic Body Radiation Therapy following pancreatic resection with a close or positive margin. The investigators hope to improve local control, and through the use of a shortened treatment schedule, allow patients to begin systemic therapy earlier.

Conditions

  • Adenocarcinoma of the Pancreas

Interventions

RADIATION

Stereotactic Body Radiation Therapy (SBRT)

An SBRT plan will be created by a medical physicist based on the PTV contoured on the CT scan. The plan will be to deliver fractionated SBRT to the isodose line best encompassing the PTV: 12 Gy x 3 fractions (36 Gy total)

Sponsors & Collaborators

  • David A. Clump, MD, PhD

    lead OTHER

Principal Investigators

  • David A Clump, MD · UPMC Hillman Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-06
Primary Completion
2018-04-01
Completion
2018-06-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01357525 on ClinicalTrials.gov